Page last updated: 2024-12-08

b 669

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

B 669: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID155807
CHEMBL ID151462
SCHEMBL ID3750119
MeSH IDM0096244

Synonyms (13)

Synonym
3-(cyclohexylimino)-3,5-dihydro-n,5-diphenyl-2-phenazinamine
78182-92-0
b 669
(3e)-3-cyclohexylimino-n,5-diphenyl-phenazin-2-amine
CHEMBL151462
3-cyclohexylimino-n,5-diphenylphenazin-2-amine
SCHEMBL3750119
b-669
b669
2-phenazinamine, 3-(cyclohexylimino)-3,5-dihydro-n,5-diphenyl-
HY-119929
CS-0078792
AKOS040747907

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"We have investigated the effects of cyclosporin A (CsA, 3-50 ng/ml) in combination with the riminophenazine agents clofazimine and B669 (60-500 ng/ml) on the mitogen- and alloantigen-activated proliferative responses of human mononuclear leukocytes (MNL), as well as on the phospholipase A2 and Na+, K+- adenosine triphosphatase activities of these cells."( Augmentative inhibition of lymphocyte proliferation by cyclosporin A combined with the riminophenazine compounds clofazimine and B669.
Anderson, R; Prinsloo, Y; van der Walt, R; van Rensburg, CE, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID144313Concentration for 100% inhibition of growth of dapsone sensitive Mycobacterium smegmatis 607 strain in vitro1988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
Clofazimine analogues active against a clofazimine-resistant organism.
AID144314100% inhibition of growth of rifampicin resistant Mycobacterium smegmatis 607 strain in vitro1988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
Clofazimine analogues active against a clofazimine-resistant organism.
AID144311100% inhibition of growth of clofazimine resistant Mycobacterium smegmatis 607 strain in vitro1988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
Clofazimine analogues active against a clofazimine-resistant organism.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (12.50)18.7374
1990's14 (87.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.44 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.18 (4.65)
Search Engine Demand Index46.54 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]